Previous Section
Review Articles
21. The molecular journey from ductal carcinoma in situ to invasive breast cancer.
- Author
- Wiechmann L; Kuerer HM; Wiechmann L; Kuerer HM;
- Institution
- Breast Center, Baylor College of Medicine, Houston, Texas, USA.
- Journal
- Cancer. 2008 May 15;112(10):2130-42.
- Abstract URL
- Click here to view abstract
22. Taxanes and gemcitabine doublets in the management of HER-2 negative metastatic breast cancer: towards optimization of association and schedule.
- Author
- Metro G; Fabi A; Russillo M; Papaldo P; De Laurentiis M; Ferretti G; Pellegrini D; Nuzzo C; Graziano V; Vici P; Introna M; Felici A; Cognetti F; Carlini P;
- Institution
- Division of Medical Oncology A, Regina Elena National Cancer Institute, Rome, Italy.
- Journal
- Anticancer Res. 2008 Mar-Apr;28(2B):1245-58.
- Abstract URL
- Click here to view abstract
23. Breast cancer in young women.
- Author
- Axelrod D; Smith J; Kornreich D; Grinstead E; Singh B; Cangiarella J; Guth AA;
- Institution
- Department of Surgery, New York University School of Medicine, New York, NY, USA.
- Journal
- J Am Coll Surg. 2008 Jun;206(3):1193-203. Epub 2008 Apr 24.
24. Ixabepilone: a new microtubule-targeting agent for breast cancer.
- Author
- Higa GM; Abraham J;
- Institution
- Mary Babb Randolph Cancer Center, School of Pharmacy, West Virginia University, Morgantown, WV 26506, USA.
- Journal
- Expert Rev Anticancer Ther. 2008 May;8(5):671-81.
- Abstract URL
- Click here to view abstract
25. Raloxifene in breast cancer prevention.
- Author
- Gennari L; Merlotti D; Paola VD; Nuti R;
- Institution
- University of Siena, Department of Internal Medicine, Endocrine-Metabolic Sciences and Biochemistry, Viale Bracci 1, 53100 Siena, Italy. gennari@unisi.it
- Journal
- Expert Opin Drug Saf. 2008 May;7(3):259-70.
- Abstract URL
- Click here to view abstract
26. Hormone therapy for breast cancer, with an emphasis on the pure antiestrogen fulvestrant: mode of action, antitumor efficacy and effects on bone health.
- Author
- Journe F; Body JJ; Leclercq G; Laurent G;
- Institution
- Universite Libre de Bruxelles (ULB), Laboratory of Endocrinology and Bone Diseases, Institut Jules Bordet, Rue Heger-Bordet 1, 1000 Brussels, Belgium. fabrice.journe@bordet.be
- Journal
- Expert Opin Drug Saf. 2008 May;7(3):241-58.
- Abstract URL
- Click here to view abstract
27. Overview of breast cancer staging and surgical treatment options.
- Author
- Hammer C; Fanning A; Crowe J;
- Institution
- Department of General Surgery, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
- Journal
- Cleve Clin J Med. 2008 Mar;75 Suppl 1:S10-6.
- Abstract URL
- Click here to view abstract
28. Pharmacotherapy of bone metastases in breast cancer patients.
- Author
- Petrut B; Simmons C; Broom R; Trinkaus M; Clemons M;
- Institution
- Resident, Internal Medicine University of Toronto, Department of Medicine, 190 Elizabeth Street, Toronto, Ontario, M5G2C4, Canada.
- Journal
- Expert Opin Pharmacother. 2008 Apr;9(6):937-45.
- Abstract URL
- Click here to view abstract
29. Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen.
- Author
- Carpenter R;
- Institution
- St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK. robert.carpenter@bartsandthelondon.nhs.uk
- Journal
- Eur J Surg Oncol. 2008 Jul;34(7):746-55. Epub 2008 Mar 4.
- Abstract URL
- Click here to view abstract
30. Major depression after breast cancer: a review of epidemiology and treatment.
- Author
- Fann JR; Thomas-Rich AM; Katon WJ; Cowley D; Pepping M; McGregor BA; Gralow J;
- Institution
- Department of Psychiatry and Behavioral Sciences, University of Washington, P.O. Box 356560, Seattle, WA 98195, USA. fann@u.washington.edu
- Journal
- Gen Hosp Psychiatry. 2008 Mar-Apr;30(2):112-26.
- Abstract URL
- Click here to view abstract
